Nicholas Westfall, MD
Urology · Grand Junction, CONPI 1538458575
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (31.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by SWAN Valley Medical Incorporated at 25.4% of the total. 2025 is the largest year on record at $19,102, more than ten times the $706 reported in 2019. Among urology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 305 payments — averaging $193.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SWAN Valley Medical Incorporated$15K
- Olympus America Inc.$13K
- Intuitive Surgical$13K
- Boston Scientific$4K
- Procept Biorobotics Corporation$3K
- Axonics, Inc.$2K
- plus $8K from 32 others
Across 3 payments — averaging $0.00 each. An ownership or investment interest held by the physician or an immediate family member.
- SWAN Valley Medical Incorporated$0
What the payments were for
- Consulting fees$18,28031%
- Speaking & faculty fees$5,0008%
- Travel & lodging$10,80418%
- Food & beverage$15,74527%
- Education$9,20016%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SWAN Valley Medical Incorporated | 7 | $14,978 |
| Olympus America Inc. | 26 | $13,487 |
| Intuitive Surgical | 50 | $13,050 |
| Boston Scientific | 50 | $4,163 |
| Procept Biorobotics Corporation | 19 | $3,158 |
| Axonics, Inc. | 47 | $1,886 |
| Coloplast | 16 | $1,580 |
| Arthrex | 5 | $1,441 |
| Valencia Technologies Corporation | 10 | $1,044 |
| Stryker | 5 | $882 |
| Teleflex LLC | 9 | $837 |
| Laborie Medical Technologies Corp. | 4 | $309 |
| Caldera Medical, Inc | 2 | $307 |
| Neotract Inc. | 5 | $263 |
| Astellas Pharma US Inc | 12 | $257 |
| Medtronic | 6 | $241 |
| Urogen Pharma, Inc. | 2 | $155 |
| Bluewind Medical | 1 | $113 |
| Histosonics, Inc. | 1 | $108 |
| Sumitomo Pharma America, Inc. | 4 | $95 |
| Progenics Pharmaceuticals, Inc. | 2 | $92 |
| Convatec Inc. | 3 | $68 |
| Palette Life Sciences, Inc. | 1 | $65 |
| KARL Storz Lithotripsy-america | 1 | $65 |
| Calyxo, Inc. | 1 | $61 |
| Bayer | 2 | $41 |
| Pfizer | 2 | $37 |
| Innovation Technologies Inc | 1 | $37 |
| Telix Pharmaceuticals | 1 | $31 |
| Myovant Sciences Inc. | 2 | $31 |
| Merck | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| AbbVie | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| BD | 1 | $16 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
| Tolmar Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$11,779
- Bovie$11,653
- AquaBeam Robotic System$2,467
- GENERAL KIDNEY STONE DISEASE$1,094
- URETERO-RENO FIBERSCOPE$940
- eCoin Device Kit$832
- 1788$762
- ALTIS$693
- Bulkamid$580
- AMS 700$481
- RESTORELLE$403
- Axonics$334
- Desara$307
- UroLift$264
- UroLift System$251
- LithoVue$229
- SpaceOAR VUE System - 10mL$220
- INTERSTIM$163
- AQUABEAM SYSTEM$148
- Optilume BPH Drug Coated Balloon Catheter$144
How this compares
$59,029 in reported general payments places this provider in the 95th percentile of 225 urology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 56 | $43,832 |
| Methenamine Hippurate | 70 | $4,689 |
| Tamsulosin Hcl | 207 | $2,139 |
| Trimethoprim | 14 | $1,037 |
| Oxybutynin Chloride ErOxybutynin Chloride | 57 | $731 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $620 |
| Finasteride | 27 | $244 |
| Cephalexin | 45 | $121 |
| Oxybutynin Chloride | 18 | $105 |
| Ciprofloxacin Hcl | 11 | $103 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $257 | $43,83256 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 225 urology providers in Colorado.
Other urology in Grand Junction
- Michael MurrayGrand Junction$33K
- Timothy VanadurongvanGrand Junction$12K
- Lawrence KarshDenver$706K
- Alexandra RogersLafayette$476K
- Derek ZukoskyGolden$442K
- James McBrideDurango$234K
- Damian SorceParker$224K
- Suzanne MerrillLone Tree$102K
- Ali SarramLone Tree$76K
- John KeferBoulder$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.